Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2015
01/21/2015EP2825171A1 Treatment of cancer with tor kinase inhibitors
01/21/2015EP2825170A1 Treatment of cancer with tor kinase inhibitors
01/21/2015EP2825169A1 Treatment of cancer with tor kinase inhibitors
01/21/2015EP2825168A1 Treatment of cancer with tor kinase inhibitors
01/21/2015EP2825167A1 An iloperidone metabolite for use in the treatment of psychiatric disorders
01/21/2015EP2825166A1 Method of treating ophthalmic conditions with kinase inhibitors
01/21/2015EP2825165A1 Thiophene-based compounds exhibiting nox4 inhibitory activity and use thereof in therapy
01/21/2015EP2825164A2 A method of treatment for acne and an anti-acne formulation
01/21/2015EP2825163A1 Method for isolating flavonoid dihydroquercetin (taxifolin) from conifer wood species
01/21/2015EP2825162A1 Compounds and methods for treating leukemia
01/21/2015EP2825161A1 Inhibitors of human ezh2, and methods of use thereof
01/21/2015EP2825160A1 A sik inhibitor for use in a method of treating an inflammatory and/or immune disorder
01/21/2015EP2825159A1 Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
01/21/2015EP2825154A1 Long acting compositions
01/21/2015EP2825044A2 Process for making cgrp receptor antagonists
01/21/2015EP2825039A2 Injectable ibuprofen formulation
01/21/2015CN204106610U 用以提高药物释放速度的组合式宫内药物释放体 To improve the drug release rate of the drug delivery body combined intrauterine
01/21/2015CN104302768A 治疗β-联蛋白相关疾病的有机组合物 Treatment of a disease associated with β- -catenin organic composition
01/21/2015CN104302670A 制造用于经皮给药的透明质酸-蛋白结合体的方法以及由该方法制造的用于经皮给药的透明质酸-蛋白结合体 Manufacture for transdermal administration of hyaluronic acid - protein conjugate and a method for transdermal administration of the hyaluronic acid produced by the method - protein conjugate
01/21/2015CN104302655A 甾醇衍生物和及其用于治疗牵涉转化的星形胶质细胞的疾病或治疗恶性血液病的用途 Sterol derivatives and their use for the treatment involves the conversion of astrocytes disease or therapeutic purposes hematologic malignancies
01/21/2015CN104302653A 抗菌的泰乐菌素衍生物及其制备方法 Antibacterial tylosin derivatives and preparation method
01/21/2015CN104302651A 锗的配位化合物、其生产方法和药物 Germanium complex compound, its production method and pharmaceutical
01/21/2015CN104302649A 基于吡唑并[1,5-a]嘧啶的化合物、包含它们的组合物及其使用方法 [1,5-a] pyrimidine and pyrazolo-based compound, compositions containing them and methods of use
01/21/2015CN104302648A 琥珀酸盐的晶形 Succinate crystal form
01/21/2015CN104302647A 新型吡啶并嘧啶衍生物及其用途 Novel pyridine and pyrimidine derivatives and their use
01/21/2015CN104302646A 可用作Raf激酶抑制剂的2-氨基, 6-苯基取代的吡啶并[2,3-d]嘧啶衍生物 Raf kinase inhibitors may be used as 2-amino-6-phenyl-substituted pyrido [2,3-d] pyrimidine derivatives
01/21/2015CN104302645A 抗菌化合物 Antibacterial compounds
01/21/2015CN104302641A 单环杂芳基环烷基二胺衍生物 Monocyclic heteroaryl cycloalkyl diamine derivative
01/21/2015CN104302640A 3,5-二氨基吡唑激酶抑制剂 3,5-diamino-pyrazol-kinase inhibitor
01/21/2015CN104302638A 用于抑制abl1、abl2和bcr-abl1的活性的苯甲酰胺衍生物 For inhibiting abl1, abl2 and bcr-abl1 activity benzamide derivatives
01/21/2015CN104302636A C型肝炎病毒抑制剂 Hepatitis C virus inhibitors
01/21/2015CN104302635A 5-[[4-[[吗啉-2-基]甲基氨基]-5-(三氟甲基)-2-吡啶基]氨基]吡嗪-2-腈及其治疗应用 5 - [[4 - [[morpholin-2-yl] methylamino] -5- (trifluoromethyl) -2-pyridinyl] amino] pyrazine-2-carbonitrile and its therapeutic use
01/21/2015CN104302634A 用于抑制abl1、abl2和bcr-abl1的活性的苯甲酰胺衍生物 For inhibiting abl1, abl2 and bcr-abl1 activity benzamide derivatives
01/21/2015CN104302633A 苯并[1,3]二氧杂环己烯衍生物和它们作为lpar5 拮抗剂的应用 Benzo [1,3] dioxin-derivatives and their use as antagonists lpar5
01/21/2015CN104302632A 作为色素沉着抑制剂的地衣硬酸及其衍生物 As pigmentation inhibitors lichen hard acid and its derivatives
01/21/2015CN104302630A 作为甲酰肽受体2调节剂的(2-脲基乙酰氨基)烷基衍生物 As a formyl peptide receptor 2 modulators (2- ureido acetamido) alkyl derivative
01/21/2015CN104302628A 羧酸化合物 Carboxylic acid compound
01/21/2015CN104302627A 用于治疗癌症的嘧啶化合物 Pyrimidine compounds for the treatment of cancer
01/21/2015CN104302626A 4,4-二取代的-1,4-二氢嘧啶及其作为治疗乙型肝炎的药物的用途 4,4-di-substituted-1,4-dihydro-pyrimidine as a treatment for hepatitis B and its use
01/21/2015CN104302625A 吡唑衍生物及其作为lpar5拮抗剂的用途 Pyrazole derivatives and their use as antagonists lpar5
01/21/2015CN104302624A 抗疟疾剂 Antimalarials
01/21/2015CN104302620A 内酰胺的合成 Lactam synthesis
01/21/2015CN104302615A 减低了环境污染物质的高度不饱和脂肪酸或高度不饱和脂肪酸乙酯及其制造方法 Reducing the height of the environmental pollutants or unsaturated fatty highly unsaturated fatty acid ethyl ester and its manufacturing method
01/21/2015CN104302614A 用于生物润滑剂和生物聚合物的生物多元醇及其制备方法 Bio-polyols and preparation of bio-lubricants and bio-polymers for
01/21/2015CN104302358A 3-芳基-5-取代的异喹啉-1-酮化合物和它们的治疗用途 3-aryl-5-substituted isoquinolin-1-one compounds and their therapeutic use
01/21/2015CN104302322A 骨·软组织中产生的巨细胞性肿瘤或软骨肉瘤的预防或治疗剂 Bone-soft tissue produced in giant cell tumor or chondrosarcoma prophylactic or therapeutic agent
01/21/2015CN104302305A 用于治疗纤维化的血管紧张素 For the treatment of fibrosis angiotensin
01/21/2015CN104302299A 活化干细胞的rna干扰 Rna interference activation of stem cells
01/21/2015CN104302298A 用于治疗急性髓细胞样白血病或慢性髓细胞样白血病的新组合产品 New combination products for the treatment of acute myeloid leukemia or chronic myeloid leukemia
01/21/2015CN104302297A 用于治疗皮肤疾病的寡糖组合物 For the treatment of skin diseases oligosaccharide composition
01/21/2015CN104302296A 用于治疗血友病a和/或冯维勒布兰德病的糖组合物 For the treatment of hemophilia and a sugar composition / or von Willebrand's disease
01/21/2015CN104302295A 用tor 激酶抑制剂治疗癌症 Tor kinase inhibitor used to treat cancer
01/21/2015CN104302294A 用于治疗淋巴组织增生性恶性肿瘤的作为磷脂酰肌醇3-激酶抑制剂的n-(3-{[(3-{[2-氯-5-(甲氧基)苯基]氨基}喹喔啉-2-基)氨基]磺酰基}苯基)-2-甲基丙氨酰胺 For the treatment of lymphoproliferative malignancies as phosphatidylinositol 3-kinase inhibitor n- (3 - {[(3 - {[2- chloro-5- (methoxy) phenyl] amino} quinolin 2- yl) amino] sulfonyl} phenyl) -2-methyl alaninamide
01/21/2015CN104302293A 用于压力性尿失禁的预防剂和/或治疗剂 Prophylactic agent for stress urinary incontinence and / or therapeutic agent
01/21/2015CN104302292A 表现出抗癌和抗增殖活性的吡啶酮酰胺以及类似物 Exhibit anti-cancer and anti-proliferative activity of the pyridone and the like amides
01/21/2015CN104302291A 苯达莫司汀的制剂 Bendamustine preparations
01/21/2015CN104302290A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
01/21/2015CN104302289A 具有激酶抑制活性的二苯基甲醇-吡唑衍生物及其用途 Having kinase inhibitory activity benzhydrol - pyrazole derivatives and their use
01/21/2015CN104302288A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和昔康类的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and pharmaceutical compositions of meloxicam
01/21/2015CN104302287A 作为蛋白质激酶抑制剂的吲哚啉-2-酮衍生物 As indol-2-one derivative of protein kinase inhibitors
01/21/2015CN104302286A 用于治疗乳腺癌的curaxin和用于鉴别可能响应的患者的方法 A method for the treatment of breast cancer patients and identification of possible responses curaxin for the
01/21/2015CN104302285A 用于治疗糖尿病性溃疡的β-羟基-β-甲基丁酸盐、精氨酸和谷氨酰胺的组合产品 For the treatment of diabetic ulcers of β- hydroxy -β- -methylbutyrate, arginine and glutamine combination products
01/21/2015CN104302284A 用于缓解尿频的延长释放制剂及其使用方法 Used to relieve urinary prolonged release formulations and methods of use
01/21/2015CN104302283A 用于治疗异常肾上腺皮质细胞疾病的化合物和方法 Treatment of abnormal cell disorders adrenal cortex compounds and methods for
01/21/2015CN104302282A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和对乙酰氨基酚或丙帕他莫的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and acetaminophen or Propacetamol pharmaceutical compositions
01/21/2015CN104302281A 包含特比萘芬与尿素的局部药物组合物 The topical pharmaceutical compositions containing terbinafine and urea
01/21/2015CN104302280A 用于治疗阿片样物质所致不良药效学响应的系统和方法 For the treatment of opioid-induced adverse pharmacodynamic systems and methods for response
01/21/2015CN104302277A 含有氟吡汀的药物制剂 Pharmaceutical preparations containing flupirtine's
01/21/2015CN104302275A 类固醇反应性皮肤病的治疗方法 Treatment of steroid-responsive dermatosis
01/21/2015CN104302274A 延迟释放的药物制剂 Delayed release pharmaceutical formulation
01/21/2015CN104302194A 含水的无菌维生素制剂 Sterile aqueous vitamin preparations
01/21/2015CN104302180A 对nedd8活化酶(nae)抑制剂的反应的生物标记 Biomarkers for nedd8 activating enzyme (nae) inhibitors reaction
01/21/2015CN104302176A 可注射布洛芬制剂 Injectable formulations of ibuprofen
01/21/2015CN104293857A 一种制备杏鲍菇低分子量多糖的方法 A method of preparing Pleurotus low molecular weight polysaccharides
01/21/2015CN104292468A 一种含桦木酸的两性复合物及制备方法和应用 Betulinic acid containing amphoteric compound and preparation method and application
01/21/2015CN104292353A 一种抗氧化天然植物多糖及其制备方法 An oxidizing natural plant polysaccharide and a preparation method of anti-
01/21/2015CN104292351A 一种茶藨子木层孔菌多糖及其制备方法和应用 One kind of Ribes Phellinus polysaccharide and its preparation method and application
01/21/2015CN104292350A 一种菊花多糖的提取工艺及应用 Extraction process and application of a chrysanthemum polysaccharide
01/21/2015CN104292321A 新的半乳凝素9 突变体蛋白质及其用途 The new galectin-9 mutant proteins and their use
01/21/2015CN104292290A 以氨基酸为连接子的胆汁酸-药物偶合物及其医药用途 Amino acid linker for bile acid - drug conjugate and medical use
01/21/2015CN104292289A 半乳糖配体及其在肝靶向脂质体中的应用 Galactose ligand and its application in liver targeting liposomes
01/21/2015CN104292278A 诃子鞣质类化合物及其制备方法和应用 Terminalia tannin compounds and its preparation method and application
01/21/2015CN104292242A 噻吩嘧啶类化合物和制剂及其制备方法和应用 Thiophene pyrimidine compounds and its preparation method and application
01/21/2015CN104292229A 2-苯氧基嘧啶酮类似物 2-phenoxy pyrimidinone analogues
01/21/2015CN104292228A 一种黄嘌呤化合物的多晶型及其制备方法、用途 Polymorphs, and a method for preparing a compound of xanthine, uses
01/21/2015CN104292227A 一种氮杂吖啶芳香环衍生物及其制备方法与应用 One kind of aromatic ring aza acridine derivative and its preparation method and application
01/21/2015CN104292226A 帕利哌酮氨基酸类衍生物及其应用 Paliperidone amino acid derivatives and its applications
01/21/2015CN104292225A 取代邻氨基苯甲酸小檗碱盐制备方法及用途 Substituted anthranilic acid salt preparation method and use of berberine
01/21/2015CN104292221A 一种新型(1s)-1,5-脱氢-1-c-[3-[[5-(4-氟苯基)-2-噻吩基]甲基]-4-甲基苯基]-d-葡萄糖醇的氨基酸共晶体及其用途 A novel (1s) -1,5- dehydro -1-c- [3 - [[5- (4- fluorophenyl) -2-thienyl] methyl] -4-methylphenyl] - d- glucose, amino acids and their use of alcohol eutectic
01/21/2015CN104292211A 地氯雷他定类一氧化氮供体及其制备方法和用途 Desloratadine class nitric oxide donor and its preparation and use
01/21/2015CN104292210A 含吡啶的一氧化氮供体类化合物、其制备方法及用途 Nitric oxide donor compounds containing pyridine and its preparation method and use
01/21/2015CN104292199A 含苄基哌嗪的染料木素衍生物制法及其对胃黏膜保护应用 Containing benzyl piperazine derivative of genistein on gastric mucosal protection law and its application
01/21/2015CN104292186A 粗根大戟中分离的大环二萜类化合物及多药耐药逆转用途 Euphorbia coarse roots isolated macrocyclic diterpenoids and multidrug resistance reversal purposes
01/21/2015CN104292170A 具有抗肿瘤作用的喹唑啉-芳基脲衍生物及其应用 With anti-tumor effect of quinazoline - aryl urea derivatives and its applications
01/21/2015CN104292163A 具有抗多种肿瘤活性的格尔德霉素类似物及其制备方法和应用 With a variety of anti-tumor activity of geldanamycin analogs and its preparation method and application
01/21/2015CN104292154A 新化合物 The new compounds
01/21/2015CN104292153A 吡仑帕奈晶型a及其制备方法 Topiramate talampanel a crystal and its preparation method
01/21/2015CN104292144A 苯氧基吡咯烷衍生物及其应用和组合物 Phenoxy-pyrrolidine derivatives and compositions and their application
01/21/2015CN104292128A 一种沙芬酰胺晶型a One kind of a crystal Safinamide
01/21/2015CN104292127A 含n-苯基酰胺类化合物抑制生物膜的形成 N- phenyl amides containing compounds inhibit the formation of biofilms
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 7860